USPTO serial 86621443
VALUMEDS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- IM, JEAN H
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with VALUMEDS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Richard Freilich
1805 5th Ave Ste 3Bay Shore, NY 11706-1761UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Allergy medications; Allergy relief medication; Amino acid preparations for medical purposes; Amino acids for nutritional purposes; Anesthetic for surgical purposes; Anesthetics for non-surgical use; Anesthetics for surgical and non-surgical use; Antibiotic creams; Antibiotic handwash; Antibiotic ointments; Antibiotic preparations; Antibiotic tablets; Antibiotics; Antifungal creams for medical use; Antihistamines; Calcium supplements; Contraceptive foams; Contraceptive preparations; Contraceptive sponges; Dental amalgams; Dental impression materials; Dental polish; Dental tablets for disclosing plaque and tartar on the teeth; Dental waxes; Deodorizing products, namely, all purpose deodorizer preparations for household, commercial and industrial use; Diagnostic agents, preparations and substances for medical purposes; Diagnostic preparations for medical purposes; Diarrhea medication; Diet capsules; Diet pills; Dietary and nutritional supplements; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary supplements consisting primarily of calcium; Dietary supplements for human consumption; Electrolyte drinks for medical purposes; Electrolyte replacement solutions; Enzyme dietary supplements; Enzymes for medical purposes; Eye washes; Eye-washes; Fungicides for medical use; Hair growth stimulants; Hemorrhoid treatment preparations; Hemorrhoidal ointments; Herbal supplements; Herbal supplements for sleeping problems; Material for repairing teeth and for dental crowns and bridges; Medical lubricant, namely, vaginal lubricants; Medicated anti-cavity dental rinses; Medicated dental rinses; Medicated diaper rash ointments and lotions; Medicated hair care preparations; Medicated lotions for treating dermatological conditions; Medicines for dental purposes; Migraine treatment preparations; Mixed antibiotic preparations; Molding wax for dental use; Nail fungus treatment preparations; Nutritional supplements consisting primarily of calcium; Oral contraceptives; Orthodontic alginate for dental impressions; Pain relief medication; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceuticals, namely, anti-infectives; Room deodorants; Sleeping pills/tablets; Topical anesthetics; Vaginal preparations, namely, antifungals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 27, 2016 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 26, 2016 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 10, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 9, 2016 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 9, 2016 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 10, 2016 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 10, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 24, 2015 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 29, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 29, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 9, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 24, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 17, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| May 16, 2015 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| May 15, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 9, 2015 | NWAP | NEW APPLICATION ENTERED | — |